Getting your Trinity Audio player ready...

Kronoverse Inc., the independent game-development company behind the CryptoFights skill-based fighting game, and member of ESIC (Esports Integrity Commission), has secured further funding via technology investment firm Persimmon Hill Ltd. and technology entrepreneur Calvin Ayre. This is Persimmon Hill’s first, and Calvin Ayre’s third, investment in Kronoverse.

CryptoFights utilizes the Kronoverse platform which replaces the games networking layer from traditional cloud servers to the Bitcoin SV (BSV) blockchain – a public and auditable ledger. This unlocks massive benefits for gaming by giving the eSports ecosystem a transparent and fair way to have game integrity. 

Kronoverse also adds value to ESIC’s mission to be the guardian of eSports integrity in different ways such as the use of blockchain technology and native-cash tournaments. Kronoverse’s use of blockchain technology opens up ways for government regulators to enforce gaming standards since all actions taken in a blockchain game are public and auditable.

Adam Kling, CEO of Kronoverse, commented: “The growth we’ve seen in a relatively short time is hugely encouraging for the company and, obviously, we hope that makes CryptoFights an exciting proposition for investors. To have people with the business and blockchain knowledge of Persimmon Hill coming on board, and further support from online gaming entrepreneur Calvin Ayre who is also a big believer in Bitcoin, is a clear endorsement for a transparent eSports experience.”

Recommended for you

UK finance body outlines support for tokenized assets
The Financial Conduct Authority unveils plans to boost tokenization in asset management, removing blockchain barriers to drive innovation and efficiency.
October 20, 2025
Fasset unveils first stablecoin-powered Islamic bank
Elsewhere, BNY Mellon is weighing turning to tokenized deposits in its $2.5 trillion-a-day transfer volume, enabling clients to move funds...
October 20, 2025
Advertisement
Advertisement
Advertisement